PSMB10 expression based on
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Comparison Statistical significance Normal-vs-Primary 2.617600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Cancer stage information is not available for 3 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Stage1
2.996400E-01
Normal-vs-Stage2
2.995200E-01
Normal-vs-Stage3
1.736820E-01
Normal-vs-Stage4
1.655600E-01
Stage1-vs-Stage2
4.711200E-01
Stage1-vs-Stage3
7.180200E-01
Stage1-vs-Stage4
9.314600E-01
Stage2-vs-Stage3
2.585000E-01
Stage2-vs-Stage4
4.734400E-01
Stage3-vs-Stage4
7.219800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient race information is not available for 5 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Caucasian
2.327200E-01
Normal-vs-AfricanAmerican
8.637500E-02
Normal-vs-Asian
8.275400E-01
Caucasian-vs-AfricanAmerican
5.265200E-01
Caucasian-vs-Asian
1.105380E-01
AfricanAmerican-vs-Asian
1.110570E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient gender information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Male
2.929400E-01
Normal-vs-Female
2.324200E-01
Male-vs-Female
7.368000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Patient age information is not available for 1 sample.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Age(21-40Yrs)
4.949600E-01
Normal-vs-Age(41-60Yrs)
9.784200E-02
Normal-vs-Age(61-80Yrs)
3.313000E-01
Normal-vs-Age(81-100Yrs)
6.035400E-01
Age(21-40Yrs)-vs-Age(41-60Yrs)
9.433200E-01
Age(21-40Yrs)-vs-Age(61-80Yrs)
6.951400E-01
Age(21-40Yrs)-vs-Age(81-100Yrs)
6.062400E-01
Age(41-60Yrs)-vs-Age(61-80Yrs)
2.534800E-01
Age(41-60Yrs)-vs-Age(81-100Yrs)
2.664400E-02
Age(61-80Yrs)-vs-Age(81-100Yrs)
2.378000E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Drinking status is not available for 80 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Non Drinker
4.463400E-01
Normal-vs-Daily Drinker
7.135600E-01
Normal-vs-Weekly Drinker
3.457600E-02
Normal-vs-Occasional Drinker
9.574200E-02
Normal-vs-Social Drinker
5.759400E-01
Non Drinker-vs-Daily Drinker
4.606800E-01
Non Drinker-vs-Weekly Drinker
2.938600E-01
Non Drinker-vs-Occasional Drinker
2.553400E-01
Non Drinker-vs-Social Drinker
8.406600E-01
Daily Drinker-vs-Weekly Drinker
9.114100E-02
Daily Drinker-vs-Occasional Drinker
8.272200E-02
Daily Drinker-vs-Social Drinker
6.853800E-01
Weekly Drinker-vs-Occasional Drinker
6.674000E-01
Weekly Drinker-vs-Social Drinker
3.564600E-01
Occasional Drinker-vs-Social Drinker
2.480400E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma
Subtype descriptions Grade 1 Well differentiated (low grade)
Grade 2 Moderately differentiated (intermediate grade) Grade 3 Poorly differentiated (high grade)
Grade 4 Undifferentiated (high grade)
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Grade 1
9.793000E-01
Normal-vs-Grade 2
3.211800E-01
Normal-vs-Grade 3
2.589600E-01
Normal-vs-Grade 4
1.000000E+00
Grade 1-vs-Grade 2
1.359570E-03
Grade 1-vs-Grade 3
6.759400E-04
Grade 1-vs-Grade 4
9.793000E-01
Grade 2-vs-Grade 3
2.476400E-01
Grade 2-vs-Grade 4
3.211800E-01
Grade 3-vs-Grade 4
2.589600E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Diabetes status information is not available for 30 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Diabetic
3.954000E-01
Normal-vs-NonDiabetic
2.548200E-01
Diabetic-vs-NonDiabetic
7.923800E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Pancreatitis status is not available for 39 samples.
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-Pancreatitis
6.634400E-01
Normal-vs-NoPancreatitis
2.556200E-01
Pancreatitis-vs-NoPancreatitis
1.781030E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Nodal metastais status is not available for 1 sample and cancer in nearby lymph nodes cannot be measured (NX) in 4 samples.
pathologic_N descriptions N0 No regional lymph node metastasis
N1 Metastases in 1 to 3 axillary lymph nodes N2 Metastases in 4 to 9 axillary lymph nodes
N3 Metastases in 10 or more axillary lymph nodes
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-N0
4.672800E-01
Normal-vs-N1
1.955380E-01
N0-vs-N1
5.448200E-01
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
PAAD : Pancreatic adenocarcinoma *
Please note that low number(<10) of normal samples considered.
Note
Whole exome sequencing data is not available for 3 samples.
TP53 mutation status is obtained from TCGA whole exome sequencing data. We downloaded Mutation Annotation Format (MAF) files (derived from VarScan2) from Genomic Data Commons portal. The sample with/without TP53 mutation were matched with RNA-seq data
Show statistics
Hide statistics
Comparison Statistical significance
Normal-vs-TP53-Mutant
6.634800E-01
Normal-vs-TP53-NonMutant
5.022300E-02
TP53-Mutant-vs-TP53-NonMutant
4.2154000000072E-05
Pan-cancer view
Methylation
Survival
Correlated genes
DepMap
